Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

4/6/2014 (1 year ago)

Catholic Online (www.catholic.org)

Drug cut in half the risk that cancer would worsen

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a potential blockbuster product for Pfizer.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

4/6/2014 (1 year ago)

Published in Health

Keywords: Pfizer, breast cancer, palbociclib


LOS ANGELES, CA (Catholic Online) - Said drug cut in half the risk that cancer would worsen, or progress, researchers said. The median time before the disease progressed or the women died was 20.2 months for those who received the drug, compared with 10.2 months for the control group.

"The magnitude of benefit we are seeing is not something commonly seen in cancer medicine studies," Dr. Richard S. Finn, a principal investigator in the study, says. Finn, an oncologist at the University of California, Los Angeles, called the results "quite groundbreaking."

No child need ever go to bed hungry -- Learn how you can help!


Known as palbociclib, the drug also appeared to prolong survival but not by a statistically significant amount. Those who received the drug lived a median of 37.5 months in contrast with 33.3 months for those in the control group.

The results from the Phase 2, or mid-stage, study were presented here at the annual meeting of the American Association for Cancer Research. Palbociclib is considered a jewel in Pfizer's product pipeline, with analysts predicting annual sales of billions of dollars. Amgen is entitled to an eight percent royalty on sales of the drug.

Some investors may have been letdown due to the drug, partly because they were not quite as good as interim results presented about halfway through the trial. At that point, the difference in median progression-free survival was 26.1 months for palbociclib versus 7.5 months for the control group.

Finn stresses that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died. Patients can use other drugs after leaving the trial, which can dilute any effect of palbociclib.

Palbociclib slows the proliferation of cancer cells by inhibiting the activity of two related enzymes involved in cell division; cyclin-dependent kinases 4 and 6.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor. While breast cancer is the initial focus, the drugs are being tested for other cancers.

Breast cancer specialists not involved in the study were encouraged -- but expressed caution. "These results are strikingly positive and with a large potential impact to patients," Dr. Josť Baselga said in a speech at the conference discussing the results.

Baselga, the physician in chief at the Memorial Sloan-Kettering Cancer Center, also said the results might have been biased because the study investigators, who determined whether tumors had progressed, knew which patients were getting palbociclib.

Dr. Eric P. Winer, chief of women's cancers at the Dana-Farber Cancer Institute in Boston, says larger studies were still needed.

"This is a small Phase 2 trial - not tiny, but not the kind of study that would typically lead to a change in practice," he said.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for March 2015
Universal:
Scientists: That those involved in scientific research may serve the well-being of the whole human person.
Evangelization: Contribution of women: That the unique contribution of women to the life of the Church may be recognized always.


Rosaries, Crosses, Prayer Cards and more... by Catholic Shopping .com


Comments


More Health

Negative relationships really are unhealthy: New research shows high blood pressure linked to stressful relationships Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Bad relationship status may cause physiological health deterioration. The research, conducted by a team from the University of Michigan, discovered men are more sensitive with regards to the stress levels of their wives or partners. These stress levels, from negative ... continue reading


Killer high heels cause long lasting body damage Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Fashion is such a big thing, especially for women. These days, for you to belong to the "it-crowd," you have to be stylish and popular in your social media posts, or you constantly have to update your fashion blog with the latest trends in clothing, shoes, and ... continue reading


Divorce, other stressful events may possibly trigger diabetes in children Watch

Image of The study said that while the causes of type 1 diabetes are unknown, it is usually preceded by the body's own immune system attacking and killing beta cells in the pancreas, which produce insulin.

By Catholic Online (NEWS CONSORTIUM)

A new study conducted in Sweden has found that traumatic events experienced in childhood - such as the divorce of parents, death or illness increases the risk of developing type 1 diabetes in children. LOS ANGELES, CA (Catholic Online) - The Swedish study ... continue reading


Rare deadly tick borne virus is worse than Lyme disease Watch

Image of

By Hannah Raissa Marfil (NEWS CONSORTIUM)

The Powassan virus, though having similar symptoms, are even worse than the Lyme disease, according to doctors. This tick borne virus is rare and potentially life-threatening, without any cure or treatment known of yet, reported by the CBS2. In a matter of minutes ... continue reading


First human head transplant to be performed by doctor critics call 'nuts' Watch

Image of Valery Spiridonov plans on being the first recipient to a human head transplant (East2WestNews).

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Suffering from the rare genetic Werdnig-Hoffman muscle wasting disease, diagnosed when he was one, Valery Spiridonov says that he is ready to undergo the first human head transplant. MUNTINLUPA, PHILIPPINES (Catholic Online) - The 30-year-old Russian computer scientist ... continue reading


Is Facebook making you depressed? Recent study finds link between Facebook and depression Watch

Image of Facebook enables people to share their lives online which also allows users to see information about their friends that they don't normally have access to.

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Researchers have discovered that Facebook users who spend more time in social media tend to compare their own lives from their friends', resulting into occurrence of depressive symptoms, according to a new study from the University of Houston. The danger lies in the ... continue reading


Man reveals secret on how he lost nearly 400 pounds Watch

Image of Brian Flemming only has 30 to 40 pounds left to go to reach his goal, and that's in excess skin.

By Hannah Raissa Marfil (NEWS CONSORTIUM)

With just 30 to 40 pounds of excess skin left for him to undergo surgery, Brian Flemming was successful in shedding out almost 400 pounds. He recently showed off his body in front of a camera, gaining enough attention to become a headline. Previously weighing 625 ... continue reading


Over diagnosed? Doctors now say that two-thirds of the people on anti-depressants may not need them Watch

Image of Medication for anxiety and medication is being prescribed to patients that are not clinically depressed, researchers say.

By Catholic Online (NEWS CONSORTIUM)

In an increasingly tense society, many doctors are handing out prescriptions for drugs that enable patients to combat feelings of moodiness and depression. Researchers now say that more than two-thirds, or 69 percent of people taking antidepressants don't meet ... continue reading


Mayo Clinic discovers mystery disease destroying lawyer Watch

Image of

By Hannah Raissa Marfil (NEWS CONSORTIUM)

Greg Widseth, a lawyer from Minnesota, had been suffering from an unknown disease. Neurologists he had visited could not figure out what was happening to him. Fortunately for Widseth, Mayo Clinic has been able to determine the neurological disease wreaking havoc on ... continue reading


Ancient remedy using natural ingredients appears to stop 'superbug' Watch

Image of Modern researchers are researching why the salve works so effectively.

By Catholic Online (NEWS CONSORTIUM)

Methicillin-resistant Staphylococcus aureus, or MRSA, a flesh infection usually transmitted over lengthy hospital stays, may have met its match in an ancient, medieval potion that uses only natural ingredients. The seemingly magical potion, which contains ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Acts 6:1-7
1 About this time, when the number of disciples was ... Read More

Psalm, Psalms 33:1-2, 4-5, 18-19
4 The word of Yahweh is straightforward, all he does ... Read More

Gospel, Luke 24:35-48
16 That evening the disciples went down to the shore ... Read More

Saint of the Day

Saint of the Day for April 18th, 2015 Image

St. Apollonius the Apologist
April 18: Martyr whose Apologia, or defense of the faith, is considered ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter